315 related articles for article (PubMed ID: 19149687)
1. Oncologic imaging end-points for the assessment of therapy response.
Serkova NJ; Garg K; Bradshaw-Pierce EL
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.
Schmidt GP; Baur-Melnyk A; Herzog P; Schmid R; Tiling R; Schmidt M; Reiser MF; Schoenberg SO
Invest Radiol; 2005 Dec; 40(12):743-53. PubMed ID: 16304476
[TBL] [Abstract][Full Text] [Related]
4. Imaging of tumor physiology: impacts on clinical radiation oncology.
Astner ST; Shi K; Vaupel P; Molls M
Exp Oncol; 2010 Sep; 32(3):149-52. PubMed ID: 21403609
[TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
[TBL] [Abstract][Full Text] [Related]
6. [Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology].
Schmidt GP; Haug A; Reiser MF; Rist C
Radiologe; 2010 Apr; 50(4):329-38. PubMed ID: 20229091
[TBL] [Abstract][Full Text] [Related]
7. Review of functional/anatomical imaging in oncology.
Histed SN; Lindenberg ML; Mena E; Turkbey B; Choyke PL; Kurdziel KA
Nucl Med Commun; 2012 Apr; 33(4):349-61. PubMed ID: 22314804
[TBL] [Abstract][Full Text] [Related]
8. Options for visualizing metastatic disease in the living body.
Helms MW; Brandt BH; Contag CH
Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Advances in oncologic imaging.
Towbin AJ; Trout AT; Roebuck DJ
Eur J Pediatr Surg; 2014 Dec; 24(6):474-81. PubMed ID: 25478668
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the combination of nuclear medicine with magnetic resonance for pre-clinical imaging.
Wagenaar DJ; Kapusta M; Li J; Patt BE
Technol Cancer Res Treat; 2006 Aug; 5(4):343-50. PubMed ID: 16866565
[TBL] [Abstract][Full Text] [Related]
13. PET/MRI: Emerging Clinical Applications in Oncology.
Fraum TJ; Fowler KJ; McConathy J
Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
[TBL] [Abstract][Full Text] [Related]
14. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
Höink AJ; Heindel W; Buerke B
Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
16. Hybrid Imaging in Oncology.
Fatima N; Zaman Mu; Gnanasegaran G; Zaman U; Shahid W; Zaman A; Tahseen R
Asian Pac J Cancer Prev; 2015; 16(14):5599-605. PubMed ID: 26320423
[TBL] [Abstract][Full Text] [Related]
17. Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.
Serkova NJ
Drug Resist Updat; 2011; 14(4-5):224-35. PubMed ID: 21640633
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous PET-MRI in oncology: a solution looking for a problem?
Yankeelov TE; Peterson TE; Abramson RG; Izquierdo-Garcia D; Arlinghaus LR; Li X; Atuegwu NC; Catana C; Manning HC; Fayad ZA; Gore JC
Magn Reson Imaging; 2012 Nov; 30(9):1342-56. PubMed ID: 22795930
[TBL] [Abstract][Full Text] [Related]
19. Imaging modalities in head-and-neck cancer patients.
Sham ME; Nishat S
Indian J Dent Res; 2012; 23(6):819-21. PubMed ID: 23649071
[TBL] [Abstract][Full Text] [Related]
20. Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) Combined with Positron Emission Tomography-Computed Tomography (PET-CT) and Video-Electroencephalography (VEEG) Have Excellent Diagnostic Value in Preoperative Localization of Epileptic Foci in Children with Epilepsy.
Wang GB; Long W; Li XD; Xu GY; Lu JX
Med Sci Monit; 2017 Jan; 23():1-10. PubMed ID: 28040805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
